AI assistant
INTUITIVE SURGICAL INC — Director's Dealing 2022
Jan 27, 2022
29809_dirs_2022-01-26_46da649f-4a2e-4f70-9b97-514739cbeb20.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2022-01-25
Reporting Person: Curet Myriam (EVP & Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-01-25 | Common Stock | M | 3000 | $139.52 | Acquired | 3285 | Direct |
| 2022-01-25 | Common Stock | S | 3000 | $263.9421 | Disposed | 285 | Direct |
| 2022-01-25 | Common Stock | M | 3000 | $109.4856 | Acquired | 3285 | Direct |
| 2022-01-25 | Common Stock | S | 3000 | $263.9421 | Disposed | 285 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-01-25 | Non-Qualified Stock Option (right to buy) | $109.4856 | M | 3000 | Disposed | 2027-08-15 | Common Stock (3000) | Direct |
| 2022-01-25 | Non-Qualified Stock Option (right to buy) | $139.52 | M | 3000 | Disposed | 2028-02-15 | Common Stock (3000) | Direct |
Footnotes
F1: These shares were exercised and sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 9, 2022.
F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $261.60 to $266.71 as follows: 953 shares sold at $261.60 to $261.67; 1,447 shares sold at $262.30 to $262.80; 900 shares sold at $263.12 to $263.20; 829 shares sold at $264.575 to $265.44; 671 shares sold at $265.44 to 265.74, and 1,200 shares sold at $266,11 to $266.71. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
F4: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.